|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||6.78 - 7.08|
|52 Week Range||2.23 - 40.00|
|Beta (5Y Monthly)||-0.46|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 15, 2016|
|1y Target Est||N/A|
Indivior PLC (LON:INDV) is calling for a public health dialogue aimed at breaking the stigmas associated with substance use disorders, including opioid use disorder (OUD) as patients face widespread challenges in the midst of COVID-19.
The company, which makes opioid addiction treatments, said as part of its streamlining plan it would also suspend merit-based pay increases and cut down on third-party expenses. "While some of the expected savings will be reinvested ... we will retain a large portion of the expected savings to preserve the group's flexibility through the COVID-19 pandemic," new Chief Executive Officer Mark Crossley said. Indivior has been hurt by legal hassles and competition even before the virus outbreak began.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...